Facebook
X
LinkedIn
ForwardCentral Nervous System
This session overviews the evolution of evidence guiding best practice for the management of central nervous system tumors, including brain metastases, gliomas, meningiomas, and the management of recurrent disease. A case-based approach is utilized, highlighting practical insights, areas of controversy and gaps in knowledge, and the newest research developments that may guide future practice.
Target Audience
The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, radiation therapists, radiation dosimetrists, nurses and all other health professionals involved in the field of radiation oncology.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Apply best evidence toward the individualized treatment of central nervous system tumors.
- Recall and implement practical recommendations in the radiation planning of malignant and benign CNS tumors.
Moderator
- Megan E. Daly, MD, University of California Irvine, Chao Family Comprehensive Cancer Center
Speaker
- Michelle Kim, MD, University of Michigan
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.75 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.75 Certificate of AttendanceThis activity was designated for 1.75 AMA PRA Category 1 Credit™.